| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1040-8428(99)00066-9 |
| P698 | PubMed publication ID | 11164714 |
| P2093 | author name string | Reale C | |
| Reale CA | |||
| Turkiewicz AM | |||
| P2860 | cites work | Breakthrough pain: definition, prevalence and characteristics | Q33435886 |
| Sr-89 therapy: strontium kinetics in disseminated carcinoma of the prostate | Q34685482 | ||
| Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype | Q35579640 | ||
| Radionuclide therapy of intractable bone pain: emphasis on strontium-89 | Q36129756 | ||
| The management of intractable bone pain: a clinician's perspective | Q36129779 | ||
| Bone metastases: pathophysiology and management policy | Q36630825 | ||
| Management of breast cancer with bone metastases | Q36697923 | ||
| Treatment of skeletal disease in breast cancer with clodronate | Q36697928 | ||
| Incidence, prevalence and distribution of bone metastases | Q37525194 | ||
| Recent advances in the pathophysiology of acute pain | Q38677627 | ||
| Interventional radiologic procedures with CT guidance in cancer pain management | Q39461182 | ||
| Causes and treatment of bone pain of malignant origin | Q39466839 | ||
| Pamidronate in patients with painful bone metastases, who failed initial treatment with hormones and/or chemotherapy | Q39469084 | ||
| Strontium-89--precursor targeted therapy for pain relief of blastic metastatic disease | Q39489473 | ||
| Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases | Q39542342 | ||
| Results up to death in the treatment of persistent cervico-thoracic (Pancoast) and thoracic malignant pain by unilateral percutaneous cervical cordotomy | Q39549657 | ||
| Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis | Q39549700 | ||
| Hormone treatments in the common 'hormone-dependent' carcinomas | Q40384760 | ||
| Radiotherapy for painful bone metastases | Q40392308 | ||
| Non-steroidal anti-inflammatory drugs and spinal nociceptive processing | Q40591639 | ||
| Acute renal toxicity associated with suramin in the treatment of prostate cancer | Q41019833 | ||
| The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions | Q41138419 | ||
| Bisphosphonates for controlling pain from metastatic bone disease | Q41155831 | ||
| Pain of terminal cancer patients | Q45188964 | ||
| Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain | Q48097606 | ||
| Pain causes in 200 patients referred to a multidisciplinary cancer pain clinic | Q51714386 | ||
| The Edmonton staging system for cancer pain: preliminary report. | Q52266786 | ||
| Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group | Q54342047 | ||
| Strontium-89 chloride for pain palliation in prostatic skeletal malignancy | Q57406976 | ||
| Bone metastases and bone pain in breast cancer. Are they closely associated? | Q66928320 | ||
| A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia | Q67993049 | ||
| A double-blind, crossover trial of intravenous clodronate in metastatic bone pain | Q68053186 | ||
| Use of diphosphonates in hypercalcaemia due to malignancy | Q68082486 | ||
| The management of spinal cord compression in patients with advanced malignancy | Q70682185 | ||
| Myelinated nociceptive afferents account for the hyperalgesia that follows a burn to the hand | Q70924783 | ||
| Radiotherapy for bone pain | Q71074410 | ||
| Effect of oral clodronate on metastatic bone pain: a double-blind, placebo-controlled study | Q72037799 | ||
| Palliative pamidronate treatment in patients with bone metastases from breast cancer | Q72072281 | ||
| Cancer of the prostate | Q72328054 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 1-11 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Critical Reviews in Oncology Hematology | Q15724423 |
| P1476 | title | Antalgic treatment of pain associated with bone metastases | |
| P478 | volume | 37 |
| Q26796465 | Advances in cancer pain from bone metastasis |
| Q35143391 | Cancer pain management and the JCAHO's pain standards: an institutional challenge |
| Q39193675 | Comparison of single versus multiple fractions for palliative treatment of painful bone metastasis: first study from north west India |
| Q54253984 | Expression of a chimeric human/salmon calcitonin gene integrated into the Saccharomyces cerevisiae genome using rDNA sequences as recombination sites. |
| Q77211805 | Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain |
| Q41257707 | Interleukin 1beta facilitates bone cancer pain in rats by enhancing NMDA receptor NR-1 subunit phosphorylation. |
| Q59137619 | Pain Management in Metastatic Bone Disease: A Literature Review |
| Q41479449 | Spinal miRNA-124 regulates synaptopodin and nociception in an animal model of bone cancer pain |
| Q47251727 | Symptom masquerade: understanding the meaning of symptoms |
| Q40810588 | Transient Receptor Potential Channel and Interleukin-17A Involvement in LTTL Gel Inhibition of Bone Cancer Pain in a Rat Model |
Search more.